Enanta Pharmaceuticals (ENTA) Long-Term Debt Repayments (2015 - 2019)
Enanta Pharmaceuticals posted quarterly Long-Term Debt Repayments of $22000.0 for Q3 2019, up 10.0% year-on-year from $20000.0 in Q3 2018, and little changed on a QoQ basis from $22000.0 in Q2 2019.
Enanta Pharmaceuticals (ENTA) has 5 years of Long-Term Debt Repayments data on file, last reported at $22000.0 in Q3 2019.
- For the quarter ending Q3 2019, Long-Term Debt Repayments rose 10.0% year-over-year to $22000.0; the trailing twelve-month figure through Sep 2019 stood at $86000.0 (up 8.86% YoY), and the FY2019 full-year result was $86000.0, up 8.86% from the prior year.
- Long-Term Debt Repayments for Q3 2019 stood at $22000.0, roughly flat from $22000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $22000.0 in Q2 2019 and bottomed at $16000.0 in Q4 2015.
- The 5-year median for Long-Term Debt Repayments is $19000.0 (2017), against an average of $19125.0.
- The widest annual swing landed in 2016, when Long-Term Debt Repayments advanced 12.5%; it then climbed 5.0% in 2019.
- A 5-year view of Long-Term Debt Repayments shows it stood at $16000.0 in 2015, then rose by 12.5% to $18000.0 in 2016, then gained by 5.56% to $19000.0 in 2017, then climbed by 10.53% to $21000.0 in 2018, then gained by 4.76% to $22000.0 in 2019.
- The last three Long-Term Debt Repayments figures came in at $22000.0 (Q3 2019), $22000.0 (Q2 2019), and $21000.0 (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 22,000.00 |
| Sep 30, 2019 | 22,000.00 |
| Jun 30, 2019 | 22,000.00 |
| Jun 30, 2019 | 22,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Dec 31, 2018 | 21,000.00 |
| Dec 31, 2018 | 21,000.00 |
| Sep 30, 2018 | 20,000.00 |
| Sep 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 20,000.00 |
| Mar 31, 2018 | 20,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Jun 30, 2017 | 18,000.00 |
| Jun 30, 2017 | 18,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Dec 31, 2016 | 18,000.00 |
| Dec 31, 2016 | 18,000.00 |
| Sep 30, 2016 | 18,000.00 |
| Sep 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Dec 31, 2015 | 16,000.00 |
| Dec 31, 2015 | 16,000.00 |